menu
    • menu

    Company profile for iECURE

    NEW Drugs in Dev: 2
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    iECURE is enabled by a foundational collaboration with James M. Wilson, M.D., Ph.D., Rose H. Weiss professor and director, Orphan Disease Center; professor in Departments of Medicine and Pediatrics, Perelman School of Medicine; and director of the Gene Therapy Program (GTP) at the University of Pennsylvania. GTP is comprised of more than 300 experts in vector engineering, discovery, early-stage development, gene therapy and g...
    iECURE is enabled by a foundational collaboration with James M. Wilson, M.D., Ph.D., Rose H. Weiss professor and director, Orphan Disease Center; professor in Departments of Medicine and Pediatrics, Perelman School of Medicine; and director of the Gene Therapy Program (GTP) at the University of Pennsylvania. GTP is comprised of more than 300 experts in vector engineering, discovery, early-stage development, gene therapy and gene editing manufacturing. GTP’s expertise forms the backbone of early R&D for iECURE, with GTP’s team responsible for executing all development work through the submission.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    iECUREUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Philadelphia, PA
    Telephone
    Telephone
    267 · 817 · 4800
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://iecure.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/iecure/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IECURE Earns FDA RMAT for ECUR-506 in Neonatal OTC Deficiency
    IECURE Earns FDA RMAT for ECUR-506 in Neonatal OTC Deficiency

    07 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260107943004/en/iECURE-Receives-FDA-Regenerative-Medicine-Advanced-Therapy-RMAT-Designation-for-ECUR-506-for-Neonatal-Onset-Ornithine-Transcarbamylase-OTC-Deficiency

    BUSINESSWIRE
    07 Jan 2026
    Share Share
    iECURE to Present ECUR-506 Data in OTC Deficiency Trials
    iECURE to Present ECUR-506 Data in OTC Deficiency Trials

    02 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251002843309/en/iECURE-to-Present-OTC-HOPE-Clinical-Trial-Data-of-ECUR-506-in-Ornithine-Transcarbamylase-Deficiency-at-the-European-Society-of-Gene-Cell-Therapy-Annual-Congress-and-the-American-Society-of-Human-Genetics-Annual-Meeting

    BUSINESSWIRE
    02 Oct 2025
    Share Share
    iECURE to Present Initial OTC-HOPE Clinical Data of ECUR-506
    iECURE to Present Initial OTC-HOPE Clinical Data of ECUR-506

    25 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250825783942/en/iECURE-to-Present-Initial-OTC-HOPE-Clinical-Trial-Data-of-ECUR-506-in-Ornithine-Transcarbamylase-Deficiency-at-6th-International-Symposium-on-UCDs-and-15th-International-Congress-of-Inborn-Errors-of-Metabolism

    BUSINESSWIRE
    25 Aug 2025
    Share Share
    iECURE to Present OTC-HOPE Data of ECUR-506 at Medical Meeting
    iECURE to Present OTC-HOPE Data of ECUR-506 at Medical Meeting

    06 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250506379506/en/iECURE-to-Present-Initial-OTC-HOPE-Clinical-Data-of-ECUR-506-in-Ornithine-Transcarbamylase-Deficiency-at-Upcoming-Medical-Meetings

    BUSINESSWIRE
    06 May 2025
    Share Share
    iECURE Gets FDA Fast Track For OTC Deficiency Therapy
    iECURE Gets FDA Fast Track For OTC Deficiency Therapy

    07 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240507362839/en

    BUSINESSWIRE
    07 May 2024
    Share Share
    iECURE Announces FDA Clearance of NDA for ECUR-506 to Initiate Trial
    iECURE Announces FDA Clearance of NDA for ECUR-506 to Initiate Trial

    04 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240404289854/en

    BUSINESSWIRE
    04 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search